Global Markets
Thermo Fisher Scientific: A Low‑Valuation Long‑Term Play
724FinanceDr. Yaman Ege
Dodge & Cox Fund signaled to long‑term investors by adding Thermo Fisher Scientific (NYSE:TMO) to its portfolio in the Q2 2026 investor letter, capitalising on a valuation dip.
Dodge & Cox’s Strategic Play: Entering Thermo Fisher
The Valuation Core of Thermo Fisher
Near‑Term Headwinds vs. Long‑Term Appeal
Portfolio Dynamics and Sector Context
Markets are treating Thermo Fisher Scientific’s temporary price compression as a fundamentally‑driven opportunity. Unlike AI‑sensitive tech stocks, the life‑science infrastructure and steady demand position the company as a durable growth engine. The fund’s move reflects a savvy effort to capture value‑dip upside while balancing portfolio risk and targeting long‑term returns.